New CT scanner could sharpen cancer radiation treatments

NCT ID NCT06056063

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tests a new FDA-approved cone-beam CT imaging system (Halcyon 4.0) for planning radiation therapy. Researchers will compare its image quality and ease of use to standard CT scans in 27 adults with various cancers. The goal is to see if the new system can improve treatment planning accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Halcyon 4.0 imaging system (a new FDA-approved cone-beam CT device)

What this could lead to

If successful, this could improve the accuracy and ease of radiation therapy planning for cancer patients.

What could go wrong

This is a very small pilot study (27 people) testing imaging quality, not treatment outcomes. The new system may not prove better than current methods.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer digestive system cancer female reproductive organ cancer head and neck cancer malignant urinary system neoplasm thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, 19104, United States